Meso Numismatics and Global Stem Cell Group extend their

0

LAS VEGAS, NV, June 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a technology company specializing in biotechnology and numismatics, is pleased to announce that its wholly owned subsidiary Global Stem Cells Group has completed the signing of an exclusive 5-year contract with Ramzan Ali Stem Cell Center to expand the company’s services to patients, physicians and product lines in Pakistan, the 5th most populous healthcare market in the world.

“This partnership aims to grow the Global Stem Cell Group (GSCG) brand by creating centers of excellence in cell therapy to meet demand in the Asian and Middle Eastern markets,” said David Christensen, CEO of MSSV. “GSCG is rapidly expanding its operations globally as it seeks to become a significant player in the lucrative health industry of regenerative medicine. Our organization partners with healthcare providers specializing in regenerative medicine with at least five years of experience in the healthcare industry to realize our expansion plan.

Ramzan Ali Stem Cell Center is an exclusive regenerative medicine service provider that treats chronic diseases, degenerative diseases and injuries via stem cell therapy in Pakistan. The organization has a team of highly qualified specialists, licensed doctors, licensed doctors and surgeons.

The alliance between GSCG and Ramzan Ali Stem Cell Center aims to establish a cutting-edge medical technology center. This partnership will cover medical training in 5 cities of the country; 4 annual training dates for doctors; an annual congress to raise awareness of the benefits of cellular medicine in Pakistan; and the launch of GSCG’s line of cellular products that it manufactures and distributes, for example, the CELLGENIC range of exosomes in lyophilized and liquid versions.

Syed Asad Ali, Managing Partner of Ramzan Ali Syed Hospital, welcomed the alliance, adding that his organization is “proud to be part of the growing GSCG family. It is a collaboration providing access to stem cell equipment, physician training, certification and stem cell training from a group with a remarkable history and great international reputation.

According to Usman Shah, Marketing Director of Ramzan Ali Syed Hospital, the coalition aims to dominate the Asian and Middle Eastern markets. “We want to bring all business areas of GSCG to Pakistan by embracing stem cell training, certification, products, production, patient care and equipment.” He adds, “This is an alliance that will allow the institution to expand to five cities in Pakistan. This move will ensure cutting-edge and affordable regenerative medical care in the country.”

“This partnership aligns with the company’s long-term goals and expansion plan,” said Benito Novas, CEO of GSCG. “Our primary goal is to make the benefits of regenerative medicine a reality for physicians and patients around the world. The company continues to grow and position itself as a market leader,” he added. “This new alliance will incorporate state-of-the-art stem cell practices and procedures. These measures will provide patients with access to effective and affordable options when looking for reliable solutions. »

“We can expect more of these exciting announcements in the near future,” concluded Christensen.

This press release should be read in conjunction with all other documents filed on www.sec.gov

For more information about Global Stem Cells Group, please visit: www.stemcellsgroup.com

About Meso Numismatics: Meso Numismatics, Corp is an emerging biotechnology and numismatic technology company. The company quickly became the hub of rare, exquisite and valuable inventory not only for the meso region, but also for exceptional items from around the world.

Meso has now added biotechnology to its portfolio and will continue to develop the business in this new direction. With the company’s breadth of business experience and technology team, the company will continue to expand the market.

Forward-looking statements

Certain information contained in this document constitutes forward-looking statements or statements that may be deemed or interpreted as forward-looking statements, such as the closing of the share exchange agreement. The words “plan”, “expect”, “anticipate”, “estimate”, “project”, “intend”, “expect”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors that could cause the actual results, performance (financial or operating) or achievements of the Company to differ from the results, performance (financial or operations) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company’s filings with the United States Securities and Exchange Commission. All forward-looking statements attributable to Meso Numismatics, Inc. are expressly qualified in their entirety by the aforesaid cautionary statement. Meso Numismatics, Inc. disclaims any obligation to update any forward-looking statements contained in this estimate, except as required by law.

For more information, please contact:

[email protected]

Phone: (800) 956-3935

Share.

Comments are closed.